Home NEWS How? When?… All questions answered about the COVID-19 vaccines and their availability

How? When?… All questions answered about the COVID-19 vaccines and their availability

334
0
COVID-19 vaccine available

The whopping query is when and how will the COVID-19 vaccines become available to the frantic and feeble populace of the sphere.

The Reuters say, ‘Pfizer Inc hand-in-hand with BioNTech SE and Moderna Inc have liberated trial data showing their COVID-19 vaccines prove to be about 95% effective at preventing the virus to adversely affect the human body, while AstraZeneca Plc said its vaccine could be up to 90% effective.’

WHEN WILL THE RESPECTIVE COMPANIES ROLL OUT A VACCINE?

All the vaccines are in processing. This year, Pfizer claims it will have enough to inoculate 25 million people, Moderna will have enough for 10 million people and AstraZeneca will have enough for more than 100 million people.

The U.S. Department of Defense and the Centers for Disease Control and Prevention (CDC) plans to start with the vaccines’ distribution in mid of December 2020 with a start-off release of 6.4 million doses nationwide.

Likewise, UK health authorities plan to wheel with an approved vaccine in December.

In the European Union, it depends wholly up to the respective country of the 27- member bloc, when and how they would like to proceed.

WHO WILL BE THE FIRST ONES TO GET AN APPROVED VACCINE AND WHEN IN THE UNITED STATES?

With all the green lights required from the U.S. Food and Drug Administration, the CDC came up with a supremacy list of the foremost beneficiaries of COVID-19 vaccines, which are as follows:

  • GROUP 1

21 million healthcare workers.

3 million residents in long-term care facilities.

  • GROUP 2

87 million people doing crucial work in jobs that cannot be done from home. (including firefighters, police, school employees, transportation workers, food and agriculture workers and food service employees)

  • GROUP 3

10 million adults having high-risk medical conditions.

53 million adults over the age of 65.

What about the population who do not fall in the mentioned groups above?

Not to worry! The U.S. public health officials stance that COVID-19 vaccines will become available in pharmacies, clinics and with the doctors for all the American citizens starting in April 2020; in effect that anyone who wants a shot can have it by the end of June 2020.

It is still vague when a vaccine will be up for grabs for children, keeping in mind the dosage requirements and their side effects. However, Pfizer and BioNTech have started testing their vaccine in clinical trials’ volunteers as young as 12.

WHEN WILL A VACCINE BE AVAILABLE IN OTHER COUNTRIES?

The European Union, Japan, Canada and Australia are operating rapid vaccine regulatory processes.

  • In the year 2020 itself, many AstraZeneca’s doses are expected to get dispatched to the United Kingdom, where health officials have said that if approved they, most likely, can begin vaccinating people in December. At the top of their priority list are the people living and working in healthcare units.
  • In Europe, the E.U. drugs regulator has said that, ‘They can lay down on the safety of a COVD-19 vaccine in December.’
  • Italy awaits to receive the first parcel post of the Pfizer-BioNTech shots and AstraZeneca’s shots in the first few months of the next year.
  • Spain angles to give out vaccine shots in January.
  • In Bulgaria, the country’s chief health inspector expects the first shipments to be made in March-April.
  • Hungary’s foreign minister said doses will dock in the spring at the earliest.
  • Germany, advanced BioNTech, expects to swing around the shots in early 2021 with mass vaccination centers in exhibition halls, airport terminals and concert venues

WHEN WILL DEVELOPING COUNTRIES HAVE ACCESS TO VACCINES?

COVAX, a program led by the World Health Organization to put together funds from well-heeled nations and non-profits to redeem and hand out vaccines to dozens of poorer countries, has raised $2 billion.

Its mission is to vaccinate 3% of the people in these countries with a final goal of reaching 20%. It has endorsed an interim accord to buy AstraZeneca’s vaccine, which does not require storage in specialized ultra-cold equipment like the Pfizer vaccine.

HOW MUCH WILL IT COST?

In the acts and tries of conferring- vaccine composers and governments have put forth differing prices. Governments have paid from a few dollars per AstraZeneca shot to up to $50 for the two-dose Pfizer systematic plan. Many countries have said they will cover the cost of vaccinating their residents.

LEAVE A REPLY

Please enter your comment!
Please enter your name here